JP Patent

JP2015157843A — ポリ（ａｄｐ−リボース）ポリメラーゼ（ｐａｒｐ）のジヒドロピリドフタラジノン阻害剤

Assigned to Biomarin Pharmaceutical Inc · Expires 2015-09-03 · 11y expired

What this patent protects

【課題】新規ポリ（ADPリボース）ポリメラーゼ活性阻害剤の提供。【解決手段】式（I）等で表される8,9-ジヒドロ-2H-ピリド[4,3,2-de]フタラジン-3(7H)-オン化合物。【選択図】なし

USPTO Abstract

【課題】新規ポリ（ADPリボース）ポリメラーゼ活性阻害剤の提供。【解決手段】式（I）等で表される8,9-ジヒドロ-2H-ピリド[4,3,2-de]フタラジン-3(7H)-オン化合物。【選択図】なし

Drugs covered by this patent

Patent Metadata

Patent number
JP2015157843A
Jurisdiction
JP
Classification
—
Expires
2015-09-03
Drug substance claim
No
Drug product claim
No
Assignee
Biomarin Pharmaceutical Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.